MusculoskeletalICD-10: M19.90Affects over 54 million adults in the United States

Arthritis

Also known as: Joint Inflammation, Osteoarthritis, Rheumatoid Arthritis, Degenerative Joint Disease

Arthritis is a broad term for conditions that cause joint inflammation, pain, and stiffness, with osteoarthritis and rheumatoid arthritis being the most common types. Osteoarthritis results from wear-and-tear damage to joint cartilage, while rheumatoid arthritis is an autoimmune disorder where the immune system attacks joint linings. Arthritis is a leading cause of disability worldwide and can significantly impact mobility and quality of life.

Last updated October 31, 2026

Understanding Arthritis

Arthritis is not one disease but a label for more than 100 conditions that inflame or damage joints, and the single most useful thing to understand is which kind you have, because the treatments barely overlap. Osteoarthritis is by far the most common: a slow failure of the joint's cartilage and underlying bone that typically affects knees, hips, hands and spine in people over 50. Rheumatoid arthritis is an autoimmune disease that attacks the joint lining symmetrically, often in the hands and feet, and can strike at any age. Psoriatic arthritis accompanies psoriasis and tends to inflame whole fingers or toes, tendons and the spine. Gout is crystal arthritis. Septic arthritis is a joint infection and a medical emergency.

In osteoarthritis the problem begins in the tissue: cartilage cells struggle to maintain the matrix, the bone beneath thickens and forms spurs, and a low-grade inflammation of the joint lining adds swelling and pain. Mechanical load, prior injury, genetics and excess weight all push the process along. In rheumatoid and psoriatic arthritis the problem begins in the immune system: antibodies and T cells target joint tissue, the synovial lining proliferates into an invasive pannus, and cytokines such as TNF and interleukin-6 drive bone erosion within months. That is why inflammatory arthritis produces prolonged morning stiffness, fatigue, raised CRP and sometimes fever, while osteoarthritis stiffness fades within 30 minutes of moving.

Osteoarthritis usually progresses slowly over decades and many people plateau. Its core care is exercise, weight management, topical and oral NSAIDs, occasional steroid injections and, for end-stage joints, replacement surgery, which is among the most successful operations in medicine. Inflammatory arthritis is different: untreated rheumatoid arthritis erodes bone in most people within two years, so guidelines call for a disease-modifying drug such as methotrexate within three months of diagnosis, escalating to biologics (TNF, IL-6 or IL-17 inhibitors) or JAK inhibitors if disease activity persists. With this treat-to-target approach, remission or low disease activity is achieved in roughly half of patients. Any joint swelling lasting more than six weeks, especially with morning stiffness over 30 minutes, deserves blood tests and a referral rather than a wait-and-see approach.

Where natural approaches fit depends entirely on the type. For osteoarthritis pain they are a legitimate adjunct and occasionally a first-line option for mild symptoms: curcumin and boswellia have multiple randomised trials showing pain reductions in the same range as NSAIDs over 8 to 12 weeks, ginger has modest trial support, and glucosamine sulfate, chondroitin and MSM have mixed but real evidence. For rheumatoid arthritis, omega-3 fish oil is the one supplement with consistent trial evidence, reducing pain, morning stiffness and NSAID use, but nothing herbal replaces disease-modifying drugs; the window for preventing joint destruction closes quickly. For gout, supplements shift urate by tenths of a point and cannot stand in for allopurinol. Evidence quality across the board is moderate at best: trials are short, often industry-funded and rarely compare directly against standard care.

The most common and most damaging misconception is that arthritis is simply ageing and nothing can be done, so people tolerate swollen joints for a year before seeing anyone. For osteoarthritis that delay costs muscle strength and fitness that are hard to rebuild. For inflammatory arthritis it costs irreversible joint damage that early treatment would have prevented. The second misconception is that rest protects joints; in reality movement nourishes cartilage, strengthens the muscles that unload the joint, and is the most evidence-backed treatment for pain across every type of arthritis.

At a Glance

Common symptoms
Joint pain and tenderness, Stiffness, especially in the morning or after inactivity, Swelling around affected joints
Main treatments
NSAIDs (ibuprofen, naproxen) for pain and inflammation, Disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis, Biologic therapies (TNF inhibitors, IL-6 inhibitors)
Category
Musculoskeletal · Affects over 54 million adults in the United States
See a doctor if
Joint pain or stiffness persists for more than a few weeks

Symptoms

Joint pain and tenderness
Stiffness, especially in the morning or after inactivity
Swelling around affected joints
Reduced range of motion
Redness and warmth around joints
Joint deformity in advanced cases
Fatigue (especially in rheumatoid arthritis)
Crepitus (grinding or crackling sensation in joints)

Causes

  • Cartilage breakdown from aging and repetitive use (osteoarthritis)
  • Autoimmune attack on joint synovium (rheumatoid arthritis)
  • Crystal deposition in joints (gout, pseudogout)
  • Joint infection (septic arthritis)
  • Genetic predisposition

Risk Factors

  • Age (risk increases with age)
  • Female sex (rheumatoid arthritis is more common in women)
  • Family history of arthritis
  • Obesity (excess weight stresses joints)
  • Previous joint injury
  • Occupations involving repetitive joint movements

Diagnosis

  • Physical examination of joint tenderness, swelling, and range of motion
  • X-rays to reveal cartilage loss and bone changes
  • MRI for detailed imaging of soft tissues and early damage
  • Blood tests (RF, anti-CCP, ESR, CRP for inflammatory arthritis)
  • Joint fluid analysis (arthrocentesis)

Treatment

  • NSAIDs (ibuprofen, naproxen) for pain and inflammation
  • Disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis
  • Biologic therapies (TNF inhibitors, IL-6 inhibitors)
  • Corticosteroid injections for acute flares
  • Physical therapy and exercise programs
  • Joint replacement surgery for severe cases

Natural remedies for arthritis: what the evidence says

Ranked by the strength of human evidence for arthritis specifically. These sit alongside medical care, not in place of it.

  1. Meta-analyses pooling more than 15 randomised trials in knee osteoarthritis find curcumin extracts reduce pain and stiffness scores significantly more than placebo over 4 to 12 weeks, with effect sizes comparable to NSAIDs. A 2014 trial of 367 patients found 1,500 mg daily of a turmeric extract matched 1,200 mg ibuprofen for pain with fewer stomach complaints. Evidence in rheumatoid arthritis is limited to one 45-patient trial where 500 mg twice daily improved disease activity scores.

    Studied dose
    500 to 1,500 mg daily of a bioavailable curcumin extract (with piperine, or phospholipid or micellar forms) with food, for at least 8 weeks.
    Cautions
    Potentiates warfarin, DOACs and antiplatelet drugs and can increase bleeding when combined with NSAIDs; may worsen reflux and gallstone pain. Rare liver injury has been reported with high-dose extracts, so avoid with methotrexate or leflunomide unless liver tests are being monitored; stop 2 weeks before surgery.
  2. In rheumatoid arthritis, a 2007 meta-analysis of 17 trials found fish oil reduced patient-reported joint pain, morning stiffness duration, number of tender joints and NSAID consumption after 3 to 4 months. In a 2015 trial of early RA, 5.5 g per day of EPA plus DHA on top of methotrexate-based therapy doubled the remission rate and reduced treatment failure. For osteoarthritis the data are weaker: a 2015 trial found low-dose fish oil (0.45 g) improved pain more than high-dose, and overall effects are modest.

    Studied dose
    2.7 g or more of combined EPA and DHA daily for inflammatory arthritis (usually 3 to 5 standard capsules, or a concentrated liquid); 1 g daily for general joint health.
    Cautions
    Modestly increases bleeding tendency with warfarin, DOACs, aspirin and high-dose NSAIDs; stop a week before surgery. High doses may raise LDL cholesterol slightly and cause loose stools; choose a product tested for oxidation and heavy metals.
  3. At least seven randomised trials in knee osteoarthritis, pooled in a 2020 meta-analysis of about 545 patients, show boswellia extracts reduce pain and stiffness and improve function versus placebo over 4 to 12 weeks, with benefit appearing within a week in some trials. One 90-day trial of 75 patients found 100 mg of an enriched extract (5-Loxin) cut pain scores by about 40 percent. Rheumatoid arthritis trials are old, small and inconclusive.

    Studied dose
    100 to 250 mg daily of an extract standardised to 30 to 65 percent boswellic acids (or AKBA-enriched extracts at 100 mg), taken with a fatty meal.
    Cautions
    Can cause nausea, reflux and diarrhoea; may interact with drugs metabolised by CYP enzymes including some statins and immunosuppressants. Avoid in pregnancy; stop before surgery because of possible antiplatelet effects.
  4. Ginger

    Moderate evidence

    A 2015 meta-analysis of five randomised trials (593 patients) found ginger extract reduced osteoarthritis pain and disability modestly versus placebo, with a 2001 trial of 261 knee patients showing 255 mg of concentrated extract twice daily for 6 weeks improved pain on standing in 63 percent versus 50 percent on placebo. In rheumatoid arthritis, a 2019 trial of 70 patients found 1.5 g ginger powder daily for 12 weeks lowered disease activity scores and inflammatory gene expression.

    Studied dose
    500 mg to 1.5 g of dried ginger powder or 250 mg standardised extract, two to three times daily with food.
    Cautions
    Mild antiplatelet effect adds to bleeding risk with anticoagulants and NSAIDs; can cause heartburn and, in large doses, affect blood sugar. Generally considered safe in pregnancy at culinary doses but keep supplemental doses under 1 g per day.
  5. Glucosamine Sulfate

    Moderate evidence

    Results are split along product lines. Trials of crystalline glucosamine sulfate 1,500 mg once daily, mostly manufacturer-funded, found pain reductions and slower joint-space narrowing over 3 years in knee osteoarthritis, while the large NIH-funded GAIT trial using glucosamine hydrochloride found no benefit over placebo overall. Independent meta-analyses conclude the effect on pain is small to none, with sulfate performing better than hydrochloride. It has no evidence in inflammatory arthritis.

    Studied dose
    1,500 mg crystalline glucosamine sulfate once daily for at least 3 months before judging.
    Cautions
    Can slightly raise blood sugar and intraocular pressure; usually made from shellfish shells, so check for allergy. Case reports suggest it may increase the effect of warfarin (raised INR); avoid in pregnancy for lack of data.
  6. Chondroitin Sulfate

    Moderate evidence

    Pharmaceutical-grade chondroitin sulfate 800 mg daily matched celecoxib 200 mg for knee osteoarthritis pain and function at 6 months in the 604-patient CONCEPT trial, and a 2015 Cochrane review found a small pain benefit over placebo, with lower-quality over-the-counter products performing worse. Two 2-year trials suggested slower cartilage loss on MRI or X-ray, though the clinical meaning is uncertain.

    Studied dose
    800 to 1,200 mg daily of pharmaceutical-grade chondroitin sulfate, alone or with glucosamine, for 3 to 6 months.
    Cautions
    Structurally similar to heparin and may increase bleeding with anticoagulants; mild stomach upset is common. Quality varies widely between brands, and some over-the-counter products contain far less than labelled.
  7. Three randomised trials in knee osteoarthritis, totalling about 170 patients, found MSM at 3 to 6 g daily for 12 weeks produced modest improvements in pain and physical function compared with placebo, with a 2006 trial of 50 patients reporting a 14-point reduction in WOMAC pain on a 100-point scale. The evidence base is small and effect sizes are modest; there are no trials in rheumatoid arthritis.

    Studied dose
    1.5 to 3 g twice daily (3 to 6 g per day) with food for 12 weeks.
    Cautions
    Generally well tolerated; can cause bloating, loose stools and insomnia if taken late in the day. No known drug interactions of significance, but long-term safety data beyond 6 months are lacking.
  8. Devil's Claw

    Preliminary evidence

    Several European trials, mostly open-label or short, suggest devil's claw extracts standardised to 50 to 100 mg harpagoside daily reduce osteoarthritis and low back pain over 8 to 12 weeks, and one 4-month trial of 122 patients found an extract equivalent to the NSAID diacerein for hip and knee pain with fewer side effects. Trial quality is low and independent replication is scarce, so it ranks below the options above.

    Studied dose
    Extract providing 50 to 100 mg harpagoside daily, divided, with meals.
    Cautions
    Stimulates stomach acid and should be avoided with peptic ulcers, reflux or gallstones; may lower blood sugar and interact with warfarin and drugs metabolised by CYP2C9. Not recommended in pregnancy.

What matters day to day

  • Keep moving: in osteoarthritis, structured exercise programmes reduce pain by about as much as oral NSAIDs across dozens of trials, and in rheumatoid arthritis regular aerobic and strength training improves function and fatigue without worsening disease activity.
  • Lose weight if you carry extra: each kilogram lost removes roughly 4 kg of load from the knee with every step, and a 10 percent weight loss halved knee pain in the 18-month IDEA trial.
  • Stop smoking: it is the strongest modifiable risk factor for rheumatoid arthritis, roughly doubling risk, and smokers respond less well to methotrexate and TNF inhibitors.
  • Eat a Mediterranean-style diet: in a 12-week randomised trial it reduced rheumatoid disease activity scores by about 0.5 points and pain by 14 percent, and it supports weight control for osteoarthritis.
  • Act within 6 weeks: joint swelling plus morning stiffness over 30 minutes lasting more than 6 weeks warrants blood tests and referral, because disease-modifying treatment started within 3 months of rheumatoid symptoms roughly doubles the chance of remission.

Prevention

  • Maintain a healthy weight to reduce joint stress
  • Exercise regularly with low-impact activities (swimming, cycling)
  • Protect joints from injury during sports and physical activity
  • Eat an anti-inflammatory diet rich in omega-3 fatty acids

When to See a Doctor

  • Joint pain or stiffness persists for more than a few weeks
  • Joints become swollen, red, or warm without explanation
  • Joint symptoms are progressively limiting your daily activities
  • You experience sudden, severe joint pain, especially with fever

Frequently Asked Questions

References

  1. Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, et al.. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clinical Interventions in Aging (2014)
  2. Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain (2007)
  3. Proudman SM, James MJ, Spargo LD, et al.. Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use. Annals of the Rheumatic Diseases (2015)
  4. Clegg DO, Reda DJ, Harris CL, et al.. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis (GAIT). New England Journal of Medicine (2006)
  5. Bartels EM, Folmer VN, Bliddal H, et al.. Efficacy and safety of ginger in osteoarthritis patients: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis and Cartilage (2015)
  6. Yu G, Xiang W, Zhang T, et al.. Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. BMC Complementary Medicine and Therapies (2020)
  7. Fraenkel L, Bathon JM, England BR, et al.. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care and Research (2021)
  8. Kolasinski SL, Neogi T, Hochberg MC, et al.. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care and Research (2020)
  9. Centers for Disease Control and Prevention. Arthritis Types (2024)View source

Related Conditions

Related from the Supplement Library

These supplements have been studied in relation to Arthritis. Always consult your healthcare provider before starting any supplement, especially if you take medications.

Have questions about Arthritis?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.